CPIM
DPLO

Columbia Partners Investment Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Columbia Partners Investment Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-39,031
Closed -$757K – 165
2018
Q3 		$757K Sell
39,031
-36,881
-49% -$785K 0.19% 133
2018
Q2 		$1.94M Buy
75,912
+14,286
+23% +$333K 0.55% 58
2018
Q1 		$1.24M Buy
+61,626
New +$1.44M 0.16% 173
2016
Q3 		– Sell
-95,287
Closed -$3.33M – 374
2016
Q2 		$3.33M Buy
+95,287
New +$3M 0.25% 129

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Columbia Partners Investment Management's DPLO Position: Q4 2018 in Review

Columbia Partners Investment Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2018, closing a stake of 39,031 shares — an estimated $757K sold.

Columbia Partners Investment Management first reported a position in DPLO in Q2 2016 and held it in 4 quarters. The position peaked at $3.33M in Q2 2016. 157 funds tracked by Wall St. Rank hold DPLO as of Q4 2018.

  • Columbia Partners Investment Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2018 after selling out during the quarter.
  • Columbia Partners Investment Management sold 39,031 DIPLOMAT PHARMACY, INC. shares in Q4 2018, an estimated $757K.
  • Columbia Partners Investment Management first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2016 and held it in 4 quarters.
  • Columbia Partners Investment Management's DIPLOMAT PHARMACY, INC. position peaked at $3.33M in Q2 2016.
  • 157 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2018.

Based on Columbia Partners Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.